Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic non-small cell lung cancer. Opdivo is often prescribed with ipilimumab (Yervoy). Opdivo is also known by… read more
Overview
Opdivo Qvantig is approved by the U.S. Food and Drug Administration (FDA) as part of a treatment regimen for non-small cell lung cancer (NSCLC) in certain scenarios. These include use in combination with…